Loading
Latest filing published 02 Aug 2021 for Candel Therapeutics, Inc., €68k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
John J. Canepa has a single filing on record, published on 2 August 2021: an open-market purchase of €68k in Candel Therapeutics, Inc. One trade is not enough to describe a pattern. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration